Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study (vol 189, pg 400, 2023)

被引：0
|
作者：
Guardala, Noel A.
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷 / 03期
关键词：
D O I：
10.1093/bjd/ljad482
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E24 / E26
页数：3
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF DUPILUMAB IN PATIENTS WITH SEVERE CHRONIC HAND ECZEMA WITH INADEQUATE RESPONSE OR INTOLERANCE TO ALITRETINOIN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIB PROOF-OF-CONCEPT STUDY
    Kamphuis, Esme
    Voorberg, Angelique
    Christ-Offers, Wietske
    Schuttelaar, Marie-Louise A.
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 29 - 29
  • [2] Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study
    Voorberg, Angelique N.
    Kamphuis, Esme
    Christoffers, Wietske A.
    Schuttelaar, Marie L. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (04) : 400 - 409
  • [3] Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
    Montgomery, Stuart A.
    Mansuy, Lucilla
    Ruth, Adam
    Bose, Anjana
    Li, Hua
    Li, Dayong
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : 363 - 369
  • [4] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Alitretinoin (BAL4079) in the Treatment of Severe Chronic Hand Eczema Refractory to Potent Topical Corticosteroid Therapy
    Fowler, Joseph F.
    Graff, Ole
    Hamedani, Abbas G.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (10) : 1198 - 1204
  • [5] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    van Vollenhoven, R.
    Aranow, C.
    Rovin, B.
    Wagner, C.
    Zhou, B.
    Gordon, R.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 78 - 78
  • [6] Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study
    Andersen, Anne Sofie Schott
    Maarbjerg, Stine
    Noory, Navid
    Heinskou, Tone Bruvik
    Forman, Julie Lyng
    Cruccu, Giorgio
    Ashina, Messoud
    Bendtsen, Lars
    LANCET NEUROLOGY, 2022, 21 (11): : 994 - 1003
  • [7] Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
    Arnold, Leslie M.
    Blauwet, Mary Beth
    Tracy, Katherine
    Cai, Na
    Walzer, Mark
    Blahunka, Paul
    Marek, Gerard J.
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 3355 - 3369
  • [8] Escitalopram for Severe Asthma and Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study
    Brown, E. Sherwood
    Howard, Christina
    Khan, David A.
    Carmody, Thomas J.
    PSYCHOSOMATICS, 2012, 53 (01) : 75 - 80
  • [9] A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis.
    Aranow, Cynthia
    van Vollenhoven, R.
    Rovin, Brad H.
    Wagner, Carrie
    Zhou, Bei
    Gordon, Robert
    Hsu, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1239 - S1239
  • [10] The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study
    Zhao, Y.
    Wu, L.
    Lu, Q.
    Gao, X.
    Zhu, X.
    Yao, X.
    Li, L.
    Li, W.
    Ding, Y.
    Song, Z.
    Liu, L.
    Dang, N.
    Zhang, C.
    Liu, X.
    Gu, J.
    Wang, J.
    Geng, S.
    Liu, Q.
    Guo, Y.
    Dong, L.
    Su, H.
    Bai, L.
    O'Malley, J. T.
    Luo, J.
    Laws, E.
    Mannent, L.
    Ruddy, M.
    Amin, N.
    Bansal, A.
    Ota, T.
    Wang, M.
    Zhang, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 633 - 641
12345